Industry & Business

Fusion Antibodies Doubling Workforce as it Targets Global Business

 Breaking News
  • Fáilte Ireland Ramps Up Brexit Preparations With €5 Million Investment Fáilte Ireland – the National Tourism Development Authority – will invest €5 million to support the tourism sector as it prepares for Brexit. The announcement marks a significant ramping up of activities to ensure Irish tourism is both ‘product-ready’ and ‘industry-ready’ ahead of the UK withdrawal from the EU. The investment comes as new figures published by Fáilte Ireland [...]...
  • €750,000 Competitive Start Fund For Start-ups in All Sectors The 2019 Competitive Start Fund (CSF) will open to all sectors for applications on Tuesday 29th January, 2019. The €750,000 fund will provide up to €50,000 in equity funding for up to 15 successful entrepreneurs and start-ups. The fund closes to applications at 3pm on Tuesday, 12th February 2019. The Competitive Start Fund provides entrepreneurs and [...]...
  • Cork Chamber to Mark its 200 Year Anniversary Cork Chamber of Commerce have launched their 200 year anniversary programme, with the announcement that the President of Ireland, Michael D. Higgins, will give the keynote speech at this year’s Annual Dinner. In his first address to a business audience since his second term inauguration, the President will address attendees at the sell-out Annual Dinner in [...]...
  • Visitors to Irish Whiskey Distilleries Up 13% in 2018 The Irish Whiskey Association (IWA) has published statistics which show that there were 923,000 visitors to Irish whiskey distilleries in 2018. This marks a 13.4% increase on 2017, when visitor numbers reached 814,000. The figures are based on returns from 13 Irish whiskey distillery visitor centres and brand homes located across the island of Ireland. Overseas [...]...
  • Ulster Bank Introduces ClearSpend – A Market-first Free Mobile App Ulster Bank has introduced the innovative ClearSpend mobile app to its Irish business customers, becoming the first bank in Ireland to put real time, company budget control in customers’ pockets. The free app was developed in partnership with Silicon Valley start-up SpendLabs. The first of its kind, ClearSpend allows businesses to set budgets at company, business [...]...

Fusion Antibodies Doubling Workforce as it Targets Global Business

Fusion Antibodies Doubling Workforce as it Targets Global Business
May 28
10:36 2018

Belfast-based Clinical Research firm, Fusion Antibodies has announced plans to create 28 new jobs. This recruitment drive, supported by Invest Northern Ireland, will help Fusion deliver its services to its growing international customer base.

The company’s antibody engineering technology assists in the development of novel biological molecules that are used as innovative drugs for human diseases including cancer, coeliac disease, chronic fungal infections and immunological indications.

Announcing the expansion, Paul Kerr, Managing Director of Fusion Antibodies, said: “Invest NI continues to provide excellent support as we look to expand the business rapidly and to capitalise on our position as a successful international CRO providing a range of antibody engineering services. The work to more than double the capacity of our laboratory and office space is expected to be completed by the end of the summer, ahead of our original schedule. The new employees will include technically skilled staff working to deliver our current services to biopharma companies.

“We are also recruiting scientists with specialised skills to work in our new product development team on the establishment of our antibody affinity maturation service and the creation of a mammalian antibody library. In addition, our growth strategy, focussed on reinvigorating and expanding our new business development and sales function, will benefit from further resource in this area.”

Invest NI has offered Fusion Antibodies £213,000 towards its job creation and marketing activities.

Grainne McVeigh, Invest NI’s Director of Life Sciences, said: “This expansion is an exciting milestone for Fusion Antibodies which is among a dynamic group of companies contributing to our growing Life and Health Sciences sector. Invest NI has been working alongside the business for many years and we are delighted to be helping Fusion Antibodies to scale up its workforce and target market opportunities with drug development and diagnostics companies across the globe.”

CAPTION:

Pictured (L-R): Grainne McVeigh, Director of Life Sciences, Invest Northern Ireland, and Paul Kerr, Managing Director of Fusion Antibodies.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4